To evaluate whether the intrapatient heterogeneity of PD-1/PD-L1 expression exists in breast cancer patients, we compared PD-1/PD-L1 expression between the primary tumour and metastatic axillary lymph nodes. This evidence concerns the gene PDCD1 and breast carcinoma.